I don’t think it’s a guess. It says as much in the announcement.
“These discussions focused on the reconciliation of AnteoTech’s clinical data set, which includes stored and direct patient samples, and the TGA’s requirements for additional clinical evidence.”
Ann: TGA Registration Update, page-82
-
- There are more pages in this discussion • 469 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.6¢ | $152.4K | 5.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 907038 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 584420 | 5 |
View Market Depth
| Last trade - 12.56pm 21/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |